OpGen In The News - OpGen

Multiplex PCR Panels for Joint Infections on the Horizon
November, 2020

Q&A: Using faster diagnostics to treat COVID-19 patients
November, 2020

Battling Bacterial Antibiotic Resistance with OpGen’s Dr. Oliver Schacht
September, 2020

OpGen CEO Oliver Schacht Appears on Infection Control Today
September, 2020

Beware the super spreaders
September, 2020

Product News: OpGen Announces CE-IVD marking and launch of molecular diagnostic SARS-CoV-2 Kit
August, 2020

OpGen Earns CE Mark for COVID-19 Diagnostic
August, 2020

Super-Spreading of COVID-19 Co-Infections Reveals a Deadly Diagnostics Gap
August, 2020

LRT panel provides specificity similar to traditional cultures with faster turnaround time
July, 2020

Lack of rapid diagnostic tools contributes to Covid-19 deaths
June, 2020

Understanding the role of technology in outbreak management: Lessons learned from COVID-19 and more
June, 2020

Facing antibiotic-resistant “Superbugs” in the fight against COVID19
June, 2020

State, private partners extend superbug fight (paywall)
June, 2020

OpGen Expands Partnership With New York State Department of Health to Detect AMR Infections
June, 2020

Antibiotic resistant co-infections: A silent killer in COVID-19 patients
May, 2020

Using Broader Diagnostics To Detect Bacterial Co-Infections And Drug Resistance In COVID-19 Patients
May, 2020

The Need for Broader Testing of COVID-19 Patients
May, 2020

OpGen, Sweden’s Karolinska Institutet to Study Bacterial Co-Infections in COVID-19 Pneumonia Patients
April, 2020

COVID-19 Patients Need to be Tested for Bacteria and Fungi, Not Just the Coronavirus
April, 2020

Technology takes the top position in outbreak management
April, 2020

Uncovering bacterial co-infections in COVID-19 patients with broader diagnostics
April, 2020

OpGen Completes Business Combination with Curetis
April, 2020

OpGen Closes On Curetis Purchase
April, 2020

Applying New Diagnostic Technologies in Long-Term Care
January, 2020

Fighting Infections with Genomic Testing: Evan Jones of OpGen Describes Exciting New Technology
January, 2020

Why cloud-based data collaboration tech could defend against superbug outbreaks
December, 2019

The Missing Link in Fighting Antibiotic Resistance
December, 2019

NPR Here & Now - OpGen in the News

New Technology Can Identify Bacteria’s Genetic Make-Up, Fight Drug Resistance
October, 2019

Digital Trends Live - OpGen in the News

OpGen CEO Evan Jones Appears on Digital Trends Live to Discuss Antibiotic Resistance
September, 2019

Improving infection control with new diagnostic technologies
September, 2019

Good Morning Washington

A new light on antibiotic resistance
September, 2019

Gaithersburg’s OpGen to combine with German molecular diagnostic company
September, 2019

OpGen Progresses on Pipeline of Highly Multiplexed Drug-Resistant Bacteria Tests
August, 2019

The growing role of rapid diagnostics and digital health In long-term care
July, 2019

OpGen’s Acuitas^® AMR Gene Panel shows potential for reducing total time to targeted therapy
June, 2019

On The Mend Episode 8
June, 2019

Diagnostic test allows outbreak testing to begin more quickly than current WGS
June, 2019

Immune to drugs: Antimicrobial resistance could kill 10 million a year
May, 2019

OpGen submits antibiotic resistance test to FDA
May, 2019

Resist This: New York State Department of Health, ILÚM, OpGen Partner to Fight Antimicrobial Resistance
May, 2019

Top stories in infectious disease: FDA rejects antibiotic to treat complicated UTIs, US measles cases highest since 1994
April, 2019

Stopping Infection Outbreaks in Their Tracks With Diagnostic Technology
April, 2019

Q&A: Preventing hospital outbreaks with surveillance technology
March, 2019

Boosting infection control with new diagnostics
March, 2019

OpGen’s Bet on Precision Antibiotics
February, 2019

Healthcare has a $20B “Super” Problem: Precision Medicine is Here to Cut Costs and Save Lives
January, 2019

Next-Gen Technologies Aim to Reform the Microbiology Lab, But Do They Pose Significant Threats to the Big Guys?
December, 2018

OpGen Receives Regulatory Approval to Market Pathogen Identification Products in Colombia
December, 2018

In Brief This Week: Precipio, OpGen, Genedrive, and Danaher
December, 2018

OpGen Completes Specimen Accrual and Testing in Acuitas^® Clinical Verification Study
November, 2018

New York State Initiative Hopes to Stop the Spread of Super Bugs
October, 2018

Solving healthcare’s $20 billion superbug problem
October, 2018

DOH joins private partners to fight ‘superbugs’
October, 2018

Healthcare’s $20B “super” problem
October, 2018

OpGen Partners With NYS DOH, Merck Subsidiary for Antimicrobial Resistance Surveillance
September, 2018

OpGen signs deal with New York health department to research superbugs
September, 2018

OpGen signs deal with New York health department to research superbug
September, 2018